# Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older

Study · id `cardio:ct-nct07828730` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07828730](<https://clinicaltrials.gov/study/NCT07828730>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07828730

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT07828730. Randomized; no masking; primary purpose screening. Start 2026-12 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT07828730, source copy `cardio:ctgov-nct07828730-2026-11-12`, retrieved 2026-11-18)
- Planned start: 2026-12 (anticipated) (ClinicalTrials.gov record NCT07828730, source copy `cardio:ctgov-nct07828730-2026-11-12`, retrieved 2026-11-18)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07828730, source copy `cardio:ctgov-nct07828730-2026-11-12`, retrieved 2026-11-18)
- Completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT07828730, source copy `cardio:ctgov-nct07828730-2026-11-12`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07828730-2026-11-12`, retrieved 2026-11-18)

## The registry's words

- Brief title: Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
- Acronym: SAGE-AS
- Condition: Moderate or Severe Aortic Stenosis
- Intervention (Device): Stethophone
- Lead sponsor: Sunnybrook Health Sciences Centre
- Lead sponsor class: OTHER
- Collaborator: KMH Cardiology and Diagnostic Centres
- Collaborator class: OTHER
- Collaborator: Sparrow Acoustics Inc.
- Collaborator class: INDUSTRY
- Collaborator: Ontario Health
- Collaborator class: UNKNOWN
- Collaborator: Canadian Cardiovascular Society
- Collaborator class: OTHER
- Collaborator: Edwards life sciences
- Collaborator class: UNKNOWN
- Collaborator: Medtronic
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Sunnybrook Health Sciences Centre (`cardio:org-sunnybrook-health-sciences-centre`)
- Registry lists this organization as a collaborator: Medtronic (`cardio:medtronic`)

## Provenance

Content hash: 65bbed1c23c5775fd8c3fdbedba2d65ef0fd7a2c6a7d92f9bf1cb7709113c03e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
